Clinical trials
Fallopian Tube Neoplasms trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 4 |
| Recruiting | 4 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 2 |
| ImmunoGen, Inc. | 2 |
| Merck Sharp & Dohme LLC | 2 |
| pharmaand GmbH | 2 |
| Amgen | 1 |
| CanariaBio Inc. | 1 |
| Daiichi Sankyo | 1 |
| Eli Lilly and Company | 1 |
| Genmab | 1 |
| Hoffmann-La Roche | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fallopian Tube Neoplasms | 18 |
| Ovarian Neoplasms | 15 |
| Carcinoma, Ovarian Epithelial | 7 |
| Peritoneal Neoplasms | 4 |
| Neoplasms | 2 |
| Adenocarcinoma, Clear Cell | 1 |
| Neoplasm Metastasis | 1 |
| Pathologic Complete Response | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.